Jeffrey H Buchalter - Net Worth and Insider Trading

Jeffrey H Buchalter Net Worth

The estimated net worth of Jeffrey H Buchalter is at least $63,815 dollars as of 2024-09-20. Jeffrey H Buchalter is the Chairman, CEO & President, Director of Enzon Pharmaceuticals Inc and owns about 453,234 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $63,815. Details can be seen in Jeffrey H Buchalter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey H Buchalter has not made any transactions after 2008-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey H Buchalter

To

Jeffrey H Buchalter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey H Buchalter owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .

Click here to see the complete history of Jeffrey H Buchalter’s form 4 insider trades.

Insider Ownership Summary of Jeffrey H Buchalter

Ticker Comapny Transaction Date Type of Owner
ENZN Enzon Pharmaceuticals Inc 2008-11-13 director & Chairman & CEO & President

Jeffrey H Buchalter Latest Holdings Summary

Jeffrey H Buchalter currently owns a total of 1 stock. Jeffrey H Buchalter owns 453,234 shares of Enzon Pharmaceuticals Inc (ENZN) as of November 13, 2008, with a value of $63,815.

Latest Holdings of Jeffrey H Buchalter

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENZN Enzon Pharmaceuticals Inc 2008-11-13 453,234 0.14 63,815

Holding Weightings of Jeffrey H Buchalter


Jeffrey H Buchalter Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey H Buchalter has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the acquisition of 50,000 shares on November 13, 2008, which cost Jeffrey H Buchalter around $164,000.

Insider Trading History of Jeffrey H Buchalter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey H Buchalter Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey H Buchalter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey H Buchalter is 38.49%. GuruFocus also compares Jeffrey H Buchalter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey H Buchalter within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey H Buchalter's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey H Buchalter

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 31.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 29.96 LIMIT LIMIT LIMIT LIMIT LIMIT

Jeffrey H Buchalter Ownership Network

Ownership Network List of Jeffrey H Buchalter

No Data

Ownership Network Relation of Jeffrey H Buchalter

Insider Network Chart

Jeffrey H Buchalter Owned Company Details

What does Enzon Pharmaceuticals Inc do?

Who are the key executives at Enzon Pharmaceuticals Inc?

Jeffrey H Buchalter is the director & Chairman & CEO & President of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .

Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary

Over the past 18 months, Jeffrey H Buchalter made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,

In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.

Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enzon Pharmaceuticals Inc Insider Transactions

No Available Data

Jeffrey H Buchalter Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey H Buchalter. Currently GuruFocus does not have mailing address information for Jeffrey H Buchalter.

Discussions on Jeffrey H Buchalter

No discussions yet.